Bio Blast Pharma Ltd. (ORPN) Stock Price, Quote, News and Overview
NASDAQ:ORPN - Nasdaq -
ORPN Quote, Performance and Key Statistics
NASDAQ:ORPN (3/25/2019, 9:30:56 PM)
11.5
+0.72 (+6.68%)
The current stock price of ORPN is 11.5 null. In the past month the price increased by 5.7%. In the past year, price decreased by -27.4%.
About ORPN
Company Profile
Bio Blast Pharma Ltd. is a clinical-stage biotechnology company. It engages in developing therapies for patients with rare and ultra-rare genetic diseases. Bio Blast products include Cabaletta to treat oculopharyngeal muscular dystrophy, Machado Joseph disease or SCA3, and Kennedy's disease or SBMA; BBrm to treat diseases caused by nonsense mutation; and mPRT to treat mitochondrial protein deficiency diseases. The Company offers its products to the healthcare and medical industries. Bio Blast Pharma Ltd. is headquartered in Tel Aviv, Israel.
Company Info
Bio Blast Pharma Ltd.
PO Box 318
Tel-Aviv Is 6100201
CEO: Fredric D. Price
Phone: 972-3573-6632
Bio Blast Pharma Ltd. / ORPN FAQ
What is the stock price of Bio Blast Pharma Ltd. today?
The current stock price of ORPN is 11.5 null. The price increased by 6.68% in the last trading session.
What is the ticker symbol for Bio Blast Pharma Ltd. stock?
The exchange symbol of Bio Blast Pharma Ltd. is ORPN and it is listed on the Nasdaq exchange.
On which exchange is ORPN stock listed?
ORPN stock is listed on the Nasdaq exchange.
What is Bio Blast Pharma Ltd. worth?
Bio Blast Pharma Ltd. (ORPN) has a market capitalization of 4.81M null. This makes ORPN a Nano Cap stock.
What are the support and resistance levels for Bio Blast Pharma Ltd. (ORPN) stock?
Bio Blast Pharma Ltd. (ORPN) has a support level at 10.71 and a resistance level at 11.51. Check the full technical report for a detailed analysis of ORPN support and resistance levels.
Should I buy Bio Blast Pharma Ltd. (ORPN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ORPN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ORPN, evaluating the profitability, health, valuation and growth aspects
- Bio Blast Pharma Ltd. (ORPN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Bio Blast Pharma Ltd. (ORPN) Sales and EPS estimates to see what analysts future expectations are.
- Bio Blast Pharma Ltd. (ORPN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Bio Blast Pharma Ltd. (ORPN) Insider and Institutional Ownership to learn about the owners and their transactions.
- Bio Blast Pharma Ltd. (ORPN) Stock Chart to make your own analysis
- Bio Blast Pharma Ltd. (ORPN) Latest news and press-releases to stay up to date.
Does Bio Blast Pharma Ltd. (ORPN) stock pay dividends?
ORPN does not pay a dividend.
What is the Price/Earnings (PE) ratio of Bio Blast Pharma Ltd. (ORPN)?
Bio Blast Pharma Ltd. (ORPN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-14.32).
ORPN Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ORPN. When comparing the yearly performance of all stocks, ORPN is one of the better performing stocks in the market, outperforming 85.22% of all stocks.
ORPN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ORPN. ORPN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ORPN Financial Highlights
Over the last trailing twelve months ORPN reported a non-GAAP Earnings per Share(EPS) of -14.32. The EPS increased by 64.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -164.14% | ||
| ROE | -188.01% | ||
| Debt/Equity | 0 |